Remove ER Remove Individual Remove Insurance Remove Provider
article thumbnail

Why Concierge, Concierge Doctor, and Concierge Medicine Are Revolutionizing Healthcare (And Why You Should Care)

Plum Health

In recent years, one of the most intriguing shifts has been the rise of concierge medicine—a model that’s redefining how patients interact with their healthcare providers. In a traditional healthcare setup, doctors are often overwhelmed with large patient rosters, leaving them with limited time for each individual.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law

Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. Providers should be aware of the other drugs prescribed to their patients. By Larry K. Complaint ¶ 58.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CDC Proposes Updating Practice Guideline for Prescribing Opioids, Warning Against Continued Misapplication

FDA Law

As explained more fully below, CDC concedes that states, insurers, pharmacies and pharmacy benefit managers have implemented laws, regulations and policies that have misapplied the 2016 guideline. We believe the proposed 2022 guideline provides much needed clarification of CDC’s recommendations for both practitioners and regulators.

article thumbnail

CDC Emphasizes Opioid Guideline is Voluntary and Should Support, Not Supplant, Patient Care

FDA Law

When starting opioid therapy for acute, subacute, or chronic pain, clinicians should prescribe immediate-release opioids instead of extended-release/long-acting (“ER/LA”) opioids. ER/LA opioids should be “reserved for severe, continuous pain.”. Methadone should not be the first choice for an ER/LA opioid.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

Though the carve-out seems at odds with FDA’s regulations requiring generic drugs to have the “same labeling” as their RLDs, such regulations specifically provide for differences arising from carved-out, patent-protected method of use. Instead, it was GSK who erred in omitting the post-MI language from the use code.

IT 52
article thumbnail

Hospital-at-Home: Bruce Leff and Tacara Soones

GeriPal

And we would provide ongoing longitudinal care to them in the home, much like the Mount Sinai Visiting Doctors programs, and other programs like that. And the treatments are different than what hospice might provide in the home setting. Patients will come into the ER, they bypass the inpatient experience entirely, and go straight home.

Hospital 115